Dexcom Expands Operations in Lithuania with New Clinical Affairs Team

Dexcom, a global leader in continuous glucose monitoring (CGM) technology, is expanding its Clinical Affairs team to Lithuania. The expansion reflects the company’s commitment to broadening its clinical research efforts within Europe. The new hires will join Dexcom’s 500-strong team at the company’s Global Business Services hub in Vilnius. 
The decision to expand follows a visit earlier this year by Dexcom’s global clinical research leadership team, who evaluated Lithuania’s potential to manage clinical studies for EMEA and US. As a result, Dexcom plans to hire specialized professionals for roles directly focused on clinical research, ranging from compliance and data analysis to clinical trial management. These new employees will play a key role in managing Clinical trials and internal product research at Dexcom’s Vilnius office. 

The Clinical Affairs team will include positions such as Senior Clinical Research Associate, Senior Quality Compliance Specialist, and Clinical Program Manager. These roles require expertise in Good Clinical Practice (GCP), regulatory compliance, and advanced data management systems – skills abundant in Lithuania’s growing life sciences sector. 

"Lithuania has proven to be an excellent fit for Dexcom due to its strong business environment, skilled workforce, and strategic location within the EMEA region. Additionally, Lithuanian hospitals possess the right competencies in endocrinology clinical trials, providing valuable expertise that supports our research and development efforts", said Stayce Beck, VP Clinical Affairs at Dexcom.

Historically, Dexcom’s clinical trials have been concentrated in the United States. However, the company is now shifting its focus to Europe as part of its global growth strategy. Dexcom’s Vilnius office, which opened in 2020, provides fertile ground for expanding the company’s clinical research efforts.

"The expertise and competencies of our GBS employees make it an ideal location to support the expansion of our clinical trials into the EMEA region. Having Clinical Affairs team members in Lithuania will enable us to streamline processes, enhance collaboration, and support the development and advancement of our products and services on a global scale", said Rosita Vasilkevičiūtė-Marčėnė, Head of Dexcom Lithuania.